Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/18712722

Int. J. Cancer 2008 Nov 15 123 10 2254-9

Download in:

View as

General Info

PMID
18712722